
Opinion|Videos|May 5, 2025
The Role of ctDNA Testing in Colorectal Cancer Management: Exploring Its Use Alongside Imaging in Challenging Cases
Author(s)John L. Marshall, MD, Mark Lewis, MD
Panelists discuss how circulating tumor DNA (ctDNA) testing serves as a complementary tool to traditional imaging in challenging colorectal cancer cases, offering molecular-level insights that can detect disease recurrence earlier, resolve ambiguous radiographic findings, and inform treatment decisions when conventional assessment methods yield inconclusive results.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Casdatifan Monotherapy Achieves Clinical Activity in Late-Line Kidney Cancer
2
Antiemetic Regimen Limits Chemo-Induced Nausea/Vomiting in Multiple Myeloma
3
The Essential Role of Clinical Social Work in Oncology
4
Intravesical Mitomycin Produces Enduring Efficacy Across NMIBC Trials
5